Theravance Biopharma, Inc. - Ordinary Shares (TBPH) News
Filter TBPH News Items
TBPH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TBPH News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest TBPH News From Around the Web
Below are the latest news stories about THERAVANCE BIOPHARMA INC that investors may wish to consider to help them evaluate TBPH as an investment opportunity.
Analysts Are Optimistic We'll See A Profit From Theravance Biopharma, Inc. (NASDAQ:TBPH)With the business potentially at an important milestone, we thought we'd take a closer look at Theravance Biopharma... |
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare ConferenceTheravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that members of its management team will hold investor meetings during the 43rd Annual J.P. Morgan Healthcare Conference, January 13-16, 2025, in San Francisco, CA. |
Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue?Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitableWhile it may not be enough for some shareholders, we think it is good to see the Theravance Biopharma, Inc... |
Theravance Biopharma to Participate in an Upcoming Investor ConferenceTheravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference on Tuesday, December 3 at 11:15 am EST (8:15 am PST/4:15 pm GMT) and will be hosting in-person meetings with the investment community at the conference. |
Theravance Biopharma Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsTheravance Biopharma ( NASDAQ:TBPH ) Third Quarter 2024 Results Key Financial Results Revenue: US$16.9m (up 7.5% from... |
Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/YTBPH beats third-quarter estimates for both sales and earnings. Increased collaboration revenues from Viatris drive year-over-year top-line performance. |
Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...Theravance Biopharma Inc (TBPH) reports robust quarterly sales growth and outlines strategic plans to enhance shareholder value amidst market challenges. |
Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue EstimatesTheravance Bio (TBPH) delivered earnings and revenue surprises of 40% and 4.71%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? |
Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder ValueTheravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2024 and announced the formation of a Strategic Review Committee to assess alternatives to unlock shareholder value. |